Skip Navigation

News & Resources

Subscribe to NHLBI Press Releases
August 4, 2015

NHLBI Media Availability: Measurement of Cholesterol Function Might Provide Link to Heart Attack Risk in Patients with Psoriasis

Scientists now report a new way to assess cholesterol that shows promise for evaluating the increased heart attack risk observed in patients with psoriasis, a common inflammatory skin disease. The new technique measures the function of high-density lipoprotein (HDL), known as “good” cholesterol, rather than HDL cholesterol concentration. The study, conducted by researchers from the National Heart Lung and Blood Institute at the National Institutes of Health (NIH), could broaden the use of the technique. The study appears in the online issue of the European Heart Journal.

July 31, 2015

NIH Seeks Comment on Agency-wide Strategic Plan

In response to a request from the Congress, NIH is developing a 5-year NIH-wide Strategic Plan to advance its mission to support research in pursuit of fundamental knowledge about the nature and behavior of living systems, and the application of that knowledge to extend healthy life and reduce illness and disability. Senior leadership and staff from all 27 Institutes, Centers, and Offices (ICOs) are contributing to the proposed direction and content of the Strategic Plan, with input from the Advisory Committee to the Director, NIH.

Subscribe to NHLBI In The News
July 1, 2015 : MedPage Today
Neal S Young M.D.

Prognosis and treatment for aplastic anemia require tailoring based on which mutations patients have among a handful of leukemia-related genes, according to a new study from researchers including NHLBI's Dr. Neal S. Young.

June 29, 2015 : The Diane Rehm Show
Toren Finkel M.D., Ph.D.

NHLBI's Dr. Toren Finkel joined a live radio panel discussion on the Diane Rehm Show to discuss his anti-aging research involving work on mice. Other panel members included National Institute on Aging's Dr. Mark Mattson and Massachusetts Institute of Technology's Leonard Guarente.

September 29, 2015 to September 30, 2015
Natcher Conference Center (Building 45), National Institutes of Health, Bethesda, Maryland
The event will bring together experts in stem cell biology, cardiovascular development, translating stem cell biology, cardiac remodelling and inflammation, vascular remodelling and inflammation, and tissue engineering/genome editing/new technologies. The emphasis will be on recent discoveries and trends. We will examine the challenges and critical questions that require answers as the field moves forward to clinical applications. The Symposium’s goals are to help the science and field move forward, to find consensus regarding the translation of stem cell biology and research into a clinical setting, and to inspire participants in their own work.
November 17, 2015
NHLBI Innovation Conference NHLBI’s Office of Translational Alliances and Coordination (OTAC) hosts the NHLBI Innovation Conference to connect small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech, medical device, and pharmaceutical industries. Attendees will see featured presentations from NHLBI-funded companies, and learn from staff about recent changes in the Federal SBIR/STTR program, and other funding opportunities and cost-free resources available to small businesses.